Plasma Protease C1-inhibitor Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 C1-inhibitors
1.2.3 Kallikrein Inhibitor (Kalbitor)
1.3 Market by Application
1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies and Outlets
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2017-2028)
2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Region
2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Size by Region (2017-2022)
2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028)
2.3 Plasma Protease C1-inhibitor Treatment Market Dynamics
2.3.1 Plasma Protease C1-inhibitor Treatment Industry Trends
2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers
2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges
2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue
3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2017-2022)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2021
3.5 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.6 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
3.7 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type
4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2017-2022)
4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028)
5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2017-2022)
5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
6.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
7.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Protease C1-inhibitor Treatment Introduction
11.2.4 CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.2.5 CSL Recent Development
11.3 Sanquin
11.3.1 Sanquin Company Detail
11.3.2 Sanquin Business Overview
11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.3.5 Sanquin Recent Development
11.4 Pharming Group
11.4.1 Pharming Group Company Detail
11.4.2 Pharming Group Business Overview
11.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Introduction
11.4.4 Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.4.5 Pharming Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of C1-inhibitors
Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2022)
Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2023-2028)
Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2017-2022)
Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Takeda Company Detail
Table 42. Takeda Business Overview
Table 43. Takeda Plasma Protease C1-inhibitor Treatment Product
Table 44. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 45. Takeda Recent Development
Table 46. CSL Company Detail
Table 47. CSL Business Overview
Table 48. CSL Plasma Protease C1-inhibitor Treatment Product
Table 49. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 50. CSL Recent Development
Table 51. Sanquin Company Detail
Table 52. Sanquin Business Overview
Table 53. Sanquin Plasma Protease C1-inhibitor Treatment Product
Table 54. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 55. Sanquin Recent Development
Table 56. Pharming Group Company Detail
Table 57. Pharming Group Business Overview
Table 58. Pharming Group Plasma Protease C1-inhibitor Treatment Product
Table 59. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 60. Pharming Group Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2021 VS 2028
Figure 2. C1-inhibitors Features
Figure 3. Kallikrein Inhibitor (Kalbitor) Features
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Independent Pharmacies and Outlets Case Studies
Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2021 VS 2028
Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2021
Figure 12. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2021
Figure 14. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 16. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 20. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2028)
Figure 28. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 36. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 40. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 43. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 44. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 45. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Industry Market Size
